| Product Code: ETC9969309 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The United States continues to see significant growth in lipids import shipments, with key exporting countries including Mexico, Italy, Spain, Metropolitan France, and Israel dominating the market in 2024. The high concentration of the Herfindahl-Hirschman Index (HHI) indicates a competitive landscape among these top exporters. A remarkable compound annual growth rate (CAGR) of 81.61% from 2020 to 2024 reflects a thriving market, with a notable growth rate of 35.22% from 2023 to 2024 showcasing continued expansion and opportunity in the lipid import sector for the United States.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Lipids Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Lipids Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Lipids Market - Industry Life Cycle |
3.4 United States (US) Lipids Market - Porter's Five Forces |
3.5 United States (US) Lipids Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United States (US) Lipids Market Revenues & Volume Share, By Lipid Systems, 2021 & 2031F |
3.7 United States (US) Lipids Market Revenues & Volume Share, By Delivery Systems, 2021 & 2031F |
3.8 United States (US) Lipids Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 United States (US) Lipids Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United States (US) Lipids Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing consumer awareness about the importance of a balanced diet and healthy fats |
4.2.2 Growing demand for functional food and dietary supplements containing lipids for health benefits |
4.2.3 Rising prevalence of chronic diseases such as cardiovascular disorders driving the consumption of specialized lipid products |
4.3 Market Restraints |
4.3.1 Stringent regulations and labeling requirements in the food and beverage industry affecting the introduction of new lipid products |
4.3.2 Fluctuating prices of raw materials impacting the production costs of lipid-based products |
4.3.3 Competition from alternative sources of healthy fats such as plant-based oils affecting market growth |
5 United States (US) Lipids Market Trends |
6 United States (US) Lipids Market, By Types |
6.1 United States (US) Lipids Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Lipids Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United States (US) Lipids Market Revenues & Volume, By Natural Lipid, 2021- 2031F |
6.1.4 United States (US) Lipids Market Revenues & Volume, By Synthetic Lipids, 2021- 2031F |
6.2 United States (US) Lipids Market, By Lipid Systems |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Lipids Market Revenues & Volume, By Bioactive Lipids, 2021- 2031F |
6.2.3 United States (US) Lipids Market Revenues & Volume, By Polymerizable Lipids, 2021- 2031F |
6.2.4 United States (US) Lipids Market Revenues & Volume, By Fluorescent Lipids, 2021- 2031F |
6.2.5 United States (US) Lipids Market Revenues & Volume, By Bacterial Lipids, 2021- 2031F |
6.2.6 United States (US) Lipids Market Revenues & Volume, By Neutral Lipids, 2021- 2031F |
6.2.7 United States (US) Lipids Market Revenues & Volume, By Headgroup Modified Lipids, 2021- 2031F |
6.3 United States (US) Lipids Market, By Delivery Systems |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Lipids Market Revenues & Volume, By Liposomes, 2021- 2031F |
6.3.3 United States (US) Lipids Market Revenues & Volume, By Solid Lipid Nanoparticles, 2021- 2031F |
6.3.4 United States (US) Lipids Market Revenues & Volume, By Nanostructures Lipid Carrier, 2021- 2031F |
6.3.5 United States (US) Lipids Market Revenues & Volume, By Transferosomes, 2021- 2031F |
6.3.6 United States (US) Lipids Market Revenues & Volume, By Niosomes, 2021- 2031F |
6.3.7 United States (US) Lipids Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United States (US) Lipids Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Lipids Market Revenues & Volume, By Pharmaceutical Industries, 2021- 2031F |
6.4.3 United States (US) Lipids Market Revenues & Volume, By Biotechnology Industries, 2021- 2031F |
6.4.4 United States (US) Lipids Market Revenues & Volume, By Cosmetic Industry, 2021- 2031F |
6.4.5 United States (US) Lipids Market Revenues & Volume, By Academic and Research Institutes, 2021- 2031F |
6.4.6 United States (US) Lipids Market Revenues & Volume, By Others, 2021- 2031F |
6.5 United States (US) Lipids Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 United States (US) Lipids Market Revenues & Volume, By Direct Tender, 2021- 2031F |
6.5.3 United States (US) Lipids Market Revenues & Volume, By Retail Sales, 2021- 2031F |
6.5.4 United States (US) Lipids Market Revenues & Volume, By Others, 2021- 2031F |
7 United States (US) Lipids Market Import-Export Trade Statistics |
7.1 United States (US) Lipids Market Export to Major Countries |
7.2 United States (US) Lipids Market Imports from Major Countries |
8 United States (US) Lipids Market Key Performance Indicators |
8.1 Research and development investment in lipid technology and innovation |
8.2 Consumer acceptance and adoption rates of new lipid products in the market |
8.3 Health trends and adoption of lipid-based products in dietary habits |
8.4 Market penetration and distribution channels for lipid products |
8.5 Regulatory compliance and approvals for new lipid formulations |
9 United States (US) Lipids Market - Opportunity Assessment |
9.1 United States (US) Lipids Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United States (US) Lipids Market Opportunity Assessment, By Lipid Systems, 2021 & 2031F |
9.3 United States (US) Lipids Market Opportunity Assessment, By Delivery Systems, 2021 & 2031F |
9.4 United States (US) Lipids Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 United States (US) Lipids Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United States (US) Lipids Market - Competitive Landscape |
10.1 United States (US) Lipids Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Lipids Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here